Skip to main content
Top
Published in: Rheumatology International 5/2006

01-03-2006 | Case Report

Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases

Authors: A. E. Yücel, H. Kart-Köseoglu, B. Demirhan, F. N. Özdemir

Published in: Rheumatology International | Issue 5/2006

Login to get access

Abstract

Cholesterol crystal embolization is a potential complication of atherosclerosis. Approximately one-third of the patients who develop this problem have a history of vascular surgery, angiography or angioplasty hours to weeks before onset. The skin and the kidneys are most frequently involved, but any organ can be affected. Livedo reticularis of the lower extremities and acrocyanosis (known as “blue toe syndrome”) are the most common cutaneous manifestations. Histological examination is the only way to definitively diagnose cholesterol crystal embolization. Recently, it has been proposed that cholesterol embolization is associated with vasculitis, and some authors have labeled this condition a “vasculitis look-alike.” There is still no specific treatment for this problem, even in cases that progress to renal failure. However, a few case reports in the literature have noted successful treatment with corticosteroids and cyclophosphamide in patients with deteriorating renal function. In this article, we describe two cases of severe cholesterol crystal embolization accompanied by renal dysfunction) and blue toe syndrome. Both patients benefited from corticosteroid and cyclophosphamide therapy.
Literature
1.
go back to reference Fine MJ, Kapoor W, Falanga V (1987) Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 38:769–784PubMedCrossRef Fine MJ, Kapoor W, Falanga V (1987) Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 38:769–784PubMedCrossRef
2.
go back to reference Lye WC, Cheah JS, Sinniah R (1993) Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol 13:489–493PubMedCrossRef Lye WC, Cheah JS, Sinniah R (1993) Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol 13:489–493PubMedCrossRef
3.
go back to reference Falanga V, Fine MJ, Kapoor WN (1986) The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 122:1194–1198PubMedCrossRef Falanga V, Fine MJ, Kapoor WN (1986) The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 122:1194–1198PubMedCrossRef
4.
go back to reference Finch TM, Ryatt KS (2000) Livedo reticularis caused by cholesterol embolization may improve with simvastatin. Br J Dermatol 143:1319–1320PubMedCrossRef Finch TM, Ryatt KS (2000) Livedo reticularis caused by cholesterol embolization may improve with simvastatin. Br J Dermatol 143:1319–1320PubMedCrossRef
5.
6.
go back to reference Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca R (2000) Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 36:1089–1109PubMed Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca R (2000) Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 36:1089–1109PubMed
7.
go back to reference Moolenaar W, Lamers CB (1995) Gastrointestinal blood loss due to cholesterol crystal embolization. J Clin Gastroenterol 21:220–223PubMedCrossRef Moolenaar W, Lamers CB (1995) Gastrointestinal blood loss due to cholesterol crystal embolization. J Clin Gastroenterol 21:220–223PubMedCrossRef
8.
go back to reference Peat DS, Mathieson PW (1996) Lessons of the week: cholesterol embol may mimic systemic vasculitis. BMJ 313:546–547PubMed Peat DS, Mathieson PW (1996) Lessons of the week: cholesterol embol may mimic systemic vasculitis. BMJ 313:546–547PubMed
9.
go back to reference Fukumoto Y, Tsutsui H, Tsuchihasi M, Masumoto A, Takeshita A (2003) Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 42:211–216PubMedCrossRef Fukumoto Y, Tsutsui H, Tsuchihasi M, Masumoto A, Takeshita A (2003) Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 42:211–216PubMedCrossRef
10.
go back to reference Ballesteres AL, Bromsoms J, Valles M, Llistosella E, Garijo G, Bernado L et al (1999) Vasculitis look-alikes: variants of renal atheroembolic disease. Nephrol Dial Transplant 14:430–433CrossRef Ballesteres AL, Bromsoms J, Valles M, Llistosella E, Garijo G, Bernado L et al (1999) Vasculitis look-alikes: variants of renal atheroembolic disease. Nephrol Dial Transplant 14:430–433CrossRef
11.
go back to reference Cappiello RA, Espinoza LR, Adelman H,Aquilar J, Vasey FB, Germain BF (1989) Cholesterol embolism: a pseudovasculitic syndrome. Semin Arthritis Rheum 18:240–246PubMedCrossRef Cappiello RA, Espinoza LR, Adelman H,Aquilar J, Vasey FB, Germain BF (1989) Cholesterol embolism: a pseudovasculitic syndrome. Semin Arthritis Rheum 18:240–246PubMedCrossRef
12.
go back to reference Sijpkens Y, Westendorp R, van Kemenade F, van Duinen S, Breedveld F (1997) Vasculitis due to cholesterol embolism. Am J Med 102:302–303PubMedCrossRef Sijpkens Y, Westendorp R, van Kemenade F, van Duinen S, Breedveld F (1997) Vasculitis due to cholesterol embolism. Am J Med 102:302–303PubMedCrossRef
13.
go back to reference Young DK, Burton MF, Herman JH (1986) Multiple cholesterol emboli syndrome simulating systemic necrotizing vasculitis. J Rheumatol 13:423–426PubMed Young DK, Burton MF, Herman JH (1986) Multiple cholesterol emboli syndrome simulating systemic necrotizing vasculitis. J Rheumatol 13:423–426PubMed
14.
go back to reference Cosserat J, Bletry O, Frances C, Wechsler B, Piette JC, Kieffer E et al (1992) Multiple cholesterol embolism mimicking periarteritis nodosa. Presse Med 21:557–564PubMed Cosserat J, Bletry O, Frances C, Wechsler B, Piette JC, Kieffer E et al (1992) Multiple cholesterol embolism mimicking periarteritis nodosa. Presse Med 21:557–564PubMed
15.
go back to reference Juillet Y, Cukier A (1981) Cholesterol embolism and pseudo-periarteritis nodosa. 3 cases. Nouv Presse Med 10:177PubMed Juillet Y, Cukier A (1981) Cholesterol embolism and pseudo-periarteritis nodosa. 3 cases. Nouv Presse Med 10:177PubMed
16.
go back to reference Belenfant X, Meyrier A, Jacquot C (1999) Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 33: 840–850PubMed Belenfant X, Meyrier A, Jacquot C (1999) Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 33: 840–850PubMed
17.
go back to reference Kato A, Ohtsuji A, Terada T, Goto T, Fukasawa H, Yasuda H et al (2002) Recovery from hemodialysis therapy in a patient with renal cholesterol crystal embolism. Nephron 92:240–243PubMedCrossRef Kato A, Ohtsuji A, Terada T, Goto T, Fukasawa H, Yasuda H et al (2002) Recovery from hemodialysis therapy in a patient with renal cholesterol crystal embolism. Nephron 92:240–243PubMedCrossRef
18.
go back to reference Elinav E, Chajek-Shaul T, Stern M (2002)Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 324:268–269PubMedCrossRef Elinav E, Chajek-Shaul T, Stern M (2002)Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 324:268–269PubMedCrossRef
19.
go back to reference Maeshima E, Yamada Y, Mune M, Yukawa S (2001) A case of cholesterol embolism with ANCA treated with corticosteroid and cyclophosphamide. Ann Rheum Dis 60:726PubMedCrossRef Maeshima E, Yamada Y, Mune M, Yukawa S (2001) A case of cholesterol embolism with ANCA treated with corticosteroid and cyclophosphamide. Ann Rheum Dis 60:726PubMedCrossRef
20.
go back to reference Mann SJ, Sos TA (2001) Treatment of atheroembolization with corticosteroids. Am J Hypertens 14:831–834PubMedCrossRef Mann SJ, Sos TA (2001) Treatment of atheroembolization with corticosteroids. Am J Hypertens 14:831–834PubMedCrossRef
21.
go back to reference Stabellini N, Cerretani D, Russo G, Rizzioli E, Gilli P (2002) Renal atheroembolic disease: evaluation of the efficacy of corticosteroid therapy. G Ital Nefrol 19:18–21PubMed Stabellini N, Cerretani D, Russo G, Rizzioli E, Gilli P (2002) Renal atheroembolic disease: evaluation of the efficacy of corticosteroid therapy. G Ital Nefrol 19:18–21PubMed
22.
go back to reference Nakahama H, Sakaguchi K (2001) Small dose oral corticosteroid treatment rapidly improved renal function in a patient with an acute aggravation of chronic renal failure due to cholesterol embolism. Nephrol Dial Transplant 16:872–873PubMedCrossRef Nakahama H, Sakaguchi K (2001) Small dose oral corticosteroid treatment rapidly improved renal function in a patient with an acute aggravation of chronic renal failure due to cholesterol embolism. Nephrol Dial Transplant 16:872–873PubMedCrossRef
23.
go back to reference Aviles B, Ubeda I, Blanco J, Barrientos A (2002) Pauci-immune extracapillary glomerulonephritis and atheromatous embolization. Am J Kidney Dis 40:847–851PubMedCrossRef Aviles B, Ubeda I, Blanco J, Barrientos A (2002) Pauci-immune extracapillary glomerulonephritis and atheromatous embolization. Am J Kidney Dis 40:847–851PubMedCrossRef
24.
25.
go back to reference Moolenaar W, Lamers CB (1996) Cholesterol crystal embolization in the Netherlands. Arch Intern Med 156:653–657PubMedCrossRef Moolenaar W, Lamers CB (1996) Cholesterol crystal embolization in the Netherlands. Arch Intern Med 156:653–657PubMedCrossRef
Metadata
Title
Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases
Authors
A. E. Yücel
H. Kart-Köseoglu
B. Demirhan
F. N. Özdemir
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0012-4

Other articles of this Issue 5/2006

Rheumatology International 5/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.